AKOS Trademark

Trademark Overview


On Monday, January 24, 2022, a trademark application was filed for AKOS with the United States Patent and Trademark Office. The USPTO has given the AKOS trademark a serial number of 97235741. The federal status of this trademark filing is ABANDONED - AFTER INTER-PARTES DECISION as of Wednesday, August 23, 2023. This trademark is owned by Enveric Biosciences, Inc.. The AKOS trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:

Pharmaceutical substances for use in the prevention, treatment and management of cancer, pain, mental health disorders, cancer related distress, anxiety, depression and post-traumatic stress disorder; pharmaceutical substances for use in the management of side effects from chemotherapy, radiation therapy, immunotherapy, and cancer treatment

Scientific and technological research services in the fields of medicine, biotechnology, and pharmaceuticals; scientific and technological research and drug development in the fields of cancer, pain, mental health disorders, cancer related distress, anxiety, depression and post-traumatic stress disorder; product development of pharmaceutical substances and medicines; pharmaceutical and medical research and development; pharmaceutical testing services; scientific laboratory services; research laboratory services relating to medicine, biotechnology, and pharmaceuticals; providing online non-downloadable software for data analytics, machine learning, knowledge management, and predictive analysis of biostatistical and treatment data in the field of medical research
akos

General Information


Serial Number97235741
Word MarkAKOS
Filing DateMonday, January 24, 2022
Status604 - ABANDONED - AFTER INTER-PARTES DECISION
Status DateWednesday, August 23, 2023
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, February 21, 2023

Trademark Statements


Goods and ServicesPharmaceutical substances for use in the prevention, treatment and management of cancer, pain, mental health disorders, cancer related distress, anxiety, depression and post-traumatic stress disorder; pharmaceutical substances for use in the management of side effects from chemotherapy, radiation therapy, immunotherapy, and cancer treatment
Goods and ServicesScientific and technological research services in the fields of medicine, biotechnology, and pharmaceuticals; scientific and technological research and drug development in the fields of cancer, pain, mental health disorders, cancer related distress, anxiety, depression and post-traumatic stress disorder; product development of pharmaceutical substances and medicines; pharmaceutical and medical research and development; pharmaceutical testing services; scientific laboratory services; research laboratory services relating to medicine, biotechnology, and pharmaceuticals; providing online non-downloadable software for data analytics, machine learning, knowledge management, and predictive analysis of biostatistical and treatment data in the field of medical research

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code8 - Abandoned
Class Status DateWednesday, August 23, 2023
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code8 - Abandoned
Class Status DateWednesday, August 23, 2023
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameAKOS BIOSCIENCES, INC.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNAPLES, FL 34103

Party NameAKOS BIOSCIENCES, INC.
Party Type11 - New Owner Before Publication
Legal Entity Type03 - Corporation
AddressNAPLES, FL 34103

Party NameEnveric Biosciences, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNaples, FL 34103

Trademark Events


Event DateEvent Description
Wednesday, August 23, 2023ABANDONMENT NOTICE E-MAILED - INTER PARTES DECISION
Wednesday, August 23, 2023ABANDONMENT - AFTER INTER PARTES DECISION
Wednesday, August 23, 2023OPPOSITION TERMINATED NO. 999999
Wednesday, August 23, 2023OPPOSITION SUSTAINED NO. 999999
Thursday, June 15, 2023OPPOSITION INSTITUTED NO. 999999
Monday, March 20, 2023EXTENSION OF TIME TO OPPOSE RECEIVED
Tuesday, February 21, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, February 21, 2023PUBLISHED FOR OPPOSITION
Wednesday, February 1, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, January 18, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, January 17, 2023EXAMINER'S AMENDMENT ENTERED
Tuesday, January 17, 2023NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Tuesday, January 17, 2023EXAMINERS AMENDMENT E-MAILED
Tuesday, January 17, 2023EXAMINERS AMENDMENT -WRITTEN
Monday, January 9, 2023PREVIOUS ALLOWANCE COUNT WITHDRAWN
Monday, January 9, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, January 6, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, January 6, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, January 6, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, October 5, 2022AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Saturday, July 16, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Saturday, July 16, 2022NON-FINAL ACTION E-MAILED
Saturday, July 16, 2022NON-FINAL ACTION WRITTEN
Monday, July 11, 2022ASSIGNED TO EXAMINER
Friday, January 28, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, January 27, 2022NEW APPLICATION ENTERED